| Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression. | Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
Appin CL, Hong C, Suwala AK, Hilz S, Mathur R, Solomon DA, Smirnov IV, Stevers NO, Shai A, Wang A, Berger MS, Chang SM, Phillips JJ, Costello JF., | 04/10/2024 |
| Clinical features combined with ultrasound characteristics to predict TERT promoter mutations in papillary thyroid carcinoma: a single-center study over the past 5 years. | Clinical features combined with ultrasound characteristics to predict TERT promoter mutations in papillary thyroid carcinoma: a single-center study over the past 5 years.
Hu Y, Xu S, Dong L, Pan Z, Zhang L, Zhan W., Free PMC Article | 04/5/2024 |
| A rare homozygous variant in TERT gene causing variable bone marrow failure, fragility fractures, rib anomalies and extremely short telomere lengths with high serum IgE. | A rare homozygous variant in TERT gene causing variable bone marrow failure, fragility fractures, rib anomalies and extremely short telomere lengths with high serum IgE.
Elbadry MI, Tawfeek A, Hirano T, El-Mokhtar MA, Kenawey M, Helmy AM, Ogawa S, Mughal MZ, Nannya Y. | 03/15/2024 |
| TERT promoter mutations in atypical melanocytic lesions: A series of seven cases with adverse melanoma-specific outcome. | TERT promoter mutations in atypical melanocytic lesions: A series of seven cases with adverse melanoma-specific outcome.
Huber R, Lee J, Borretta L, Tessier-Cloutier B, Lum A, Yip S, Horst BA. | 02/24/2024 |
| Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases. | Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases.
Mervic A, Goricar K, Blagus T, Franko A, Trebusak-Podkrajsek K, Fikfak MD, Dolzan V, Kovac V., Free PMC Article | 02/23/2024 |
| TERT single nucleotide polymorphism rs2736098 but not rs2736100 is associated with telomere length in HIV-infected patients on cART. | TERT single nucleotide polymorphism rs2736098 but not rs2736100 is associated with telomere length in HIV-infected patients on cART.
Bukic E, Dragovic G, Toljic B, Obradovic B, Jadzic J, Jevtovic D, Milasin JM. | 02/7/2024 |
| The regulations of telomerase reverse transcriptase (TERT) in cancer. | The regulations of telomerase reverse transcriptase (TERT) in cancer.
Liu M, Zhang Y, Jian Y, Gu L, Zhang D, Zhou H, Wang Y, Xu ZX., Free PMC Article | 01/30/2024 |
| TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab. | TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.
Mollica V, Tassinari E, Santoni M, Marchese PV, Giunchi F, Maloberti T, Tateo V, Ricci C, Rosellini M, Marchetti A, Fiorentino M, Biase D, Massari F. | 01/29/2024 |
| Identification of IDH and TERTp mutations using dynamic susceptibility contrast MRI with deep learning in 162 gliomas. | Identification of IDH and TERTp mutations using dynamic susceptibility contrast MRI with deep learning in 162 gliomas.
Buz-Yalug B, Turhan G, Cetin AI, Dindar SS, Danyeli AE, Yakicier C, Pamir MN, Özduman K, Dincer A, Ozturk-Isik E. | 01/17/2024 |
| Genetic association study of TERT gene variants with chronic kidney disease susceptibility in the Chinese population. | Genetic association study of TERT gene variants with chronic kidney disease susceptibility in the Chinese population.
Su Y, Feng Y, Lin X, Ma C, Wei J., Free PMC Article | 01/11/2024 |
| Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation. | Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation.
Kim MK, Park H, Oh YL, Shin JH, Kim TH, Hahn SY., Free PMC Article | 01/10/2024 |
| Telomerase reverse transcriptase gene polymorphisms and cervical cancer susceptibility in high-risk human papillomavirus-infected women. | Telomerase reverse transcriptase gene polymorphisms and cervical cancer susceptibility in high-risk human papillomavirus-infected women.
Sun S, Wang Y, Liu Y, Leng Z, Jiang Y, Liang Y, Jiang Z. | 01/8/2024 |
| Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii. | Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S, Trecourt A, Lopez J, Just PA, Descotes F, Borson-Chazot F, Ray-Coquard I, Decaussin-Petrucci M, Devouassoux-Shisheboran M. | 12/28/2023 |
| TERT promoter mutations and gene amplification in endometrial cancer. | TERT promoter mutations and gene amplification in endometrial cancer.
Praiss AM, Marra A, Zhou Q, Rios-Doria E, Momeni-Boroujeni A, Iasonos A, Selenica P, Brown DN, Aghajanian C, Abu-Rustum NR, Ellenson LH, Weigelt B., | 12/22/2023 |
| [Significance of TERT promoter mutation in differential diagnosis of non-invasive inverted urothelial lesions of bladder]. | [Significance of TERT promoter mutation in differential diagnosis of non-invasive inverted urothelial lesions of bladder].
Zhang YH, Xie JJ, Wang JG, Wang Y, Zhan XH, Gao J, He HY. | 12/18/2023 |
| TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma. | TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma.
Webersinke G, Burghofer J, Malli T, Rammer M, Jahn SW, Niendorf A, Tavassoli FA, Moinfar F. | 12/1/2023 |
| TERT promoter mutations in thyroid cancer. | TERT promoter mutations in thyroid cancer.
Matsuse M, Mitsutake N. | 12/1/2023 |
| Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method. | Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method.
Capar Gorali B, Gulec Yılmaz S, Akdeniz FT, Attar R, İsbir T. | 11/29/2023 |
| Association of a Single Nucleotide Variant in TERT with Airway Disease in Japanese Rheumatoid Arthritis Patients. | Association of a Single Nucleotide Variant in TERT with Airway Disease in Japanese Rheumatoid Arthritis Patients.
Higuchi T, Oka S, Furukawa H, Shimada K, Tsunoda S, Ito S, Okamoto A, Fujimori M, Nakamura T, Katayama M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S., Free PMC Article | 11/27/2023 |
| Association of Genetic Polymorphisms of TERT with Telomere Length in Coke Oven Emissions-Exposed Workers. | Association of Genetic Polymorphisms of TERT with Telomere Length in Coke Oven Emissions-Exposed Workers.
Yan M, Cheng S, Wang S, Duan X, Mensah AR, Li L, Zhang Y, Li G, Zhao J, Feng F, Zhou X, Wu Y, Yang Y, Wang W. | 11/27/2023 |
| A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile. | A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile.
Muench A, Teichmann D, Spille D, Kuzman P, Perez E, May SA, Mueller WC, Kombos T, Nazari-Dehkordi S, Onken J, Vajkoczy P, Ntoulias G, Bettencourt C, von Deimling A, Paulus W, Heppner FL, Koch A, Capper D, Kaul D, Thomas C, Schweizer L. | 11/22/2023 |
| Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations. | Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
Cheng X, Zhou Y, Xu S, Yu H, Wu J, Bao J, Zhang L. | 11/18/2023 |
| Transition Mutations in the hTERT Promoter Are Unrelated to Potential i-motif Formation in the C-Rich Strand. | Transition Mutations in the hTERT Promoter Are Unrelated to Potential i-motif Formation in the C-Rich Strand.
Conrad JW, Sowers ML, Yap DY, Cherryhomes E, Pettitt BM, Khanipov K, Sowers LC., Free PMC Article | 11/18/2023 |
| TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas. | TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
Saito Y, Kage H, Kobayashi K, Yoshida M, Fukuoka O, Yamamura K, Mukai T, Oda K, Yamasoba T. | 11/16/2023 |
| Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma. | Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
Heo J, Lee S, Park J, Yang H, Park H, Ki CS, Oh YL, Kim HI, Kim SW, Chung JH, Kim K, Kim TH., Free PMC Article | 11/15/2023 |